Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  PerkinElmer    PKI

PERKINELMER (PKI)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

PerkinElmer, Inc. : PerkinElmer Board Declares Quarterly Dividend

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/25/2013 | 10:10pm CEST

The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 25, 2013. This dividend is payable on May 10, 2013, to all shareholders of record at the close of business on April 19, 2013.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,400 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Investor Relations:
PerkinElmer, Inc.
Tommy J. Thomas, 781-663-5889
[email protected]
or
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PERKINELMER
06/20PERKINELMER : Application Notes 2018
AQ
06/15PERKINELMER : Laboratory equipment service agreement
AQ
06/05GLOBAL MICROFLUIDICS TECHNOLOGY MARK : Application, Production, Growth Factors, ..
AQ
06/04PERKINELMER : or equal) MicroCT Scanner Upgrade
AQ
06/04PERKINELMER : acquires Chinese instrument maker
AQ
06/01PERKINELMER : to Present at Goldman Sachs Global Healthcare Conference
BU
05/29PERKINELMER : Report
CO
05/24PERKINELMER : 66-- PerkinElmer Tri-Carb 4910TR Liquid Scintillation Counter
AQ
05/22PERKINELMER : 66-- PerkinElmer Tri-Carb 4910TR Liquid Scintillation Counter
AQ
05/17PERKINELMER : to Present at UBS Global Healthcare Conference 2018
AQ
More news
News from SeekingAlpha
05/15Kiniksa Pharmaceuticals Aims For $126 Million U.S. IPO 
05/08METTLER TOLEDO : Still Not Attractive Enough 
05/04Kiniksa Pharmaceuticals Files For $100 Million IPO 
05/04PerkinElmer Lagging A Bit 
04/30PerkinElmer's (PKI) CEO Rob Friel on Q1 2018 Results - Earnings Call Transcri.. 
Financials ($)
Sales 2018 2 802 M
EBIT 2018 543 M
Net income 2018 278 M
Debt 2018 1 543 M
Yield 2018 0,38%
P/E ratio 2018 29,86
P/E ratio 2019 25,76
EV / Sales 2018 3,49x
EV / Sales 2019 3,21x
Capitalization 8 227 M
Chart PERKINELMER
Duration : Period :
PerkinElmer Technical Analysis Chart | PKI | US7140461093 | 4-Traders
Technical analysis trends PERKINELMER
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 82,8 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Robert F. Friel Chairman, President & Chief Executive Officer
Tajinder Vohra Senior Vice President-Global Operations
James M. Mock Chief Financial Officer & Senior Vice President
Nicholas A. Lopardo Independent Director
Alexis Platon Michas Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PERKINELMER1.70%8 227
THERMO FISHER SCIENTIFIC9.94%83 985
DANAHER CORPORATION6.98%69 368
INTUITIVE SURGICAL32.41%54 745
BOSTON SCIENTIFIC CORPORATION31.59%45 009
ILLUMINA29.37%41 550